Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00174Z
Serotype : AAV Serotype 3 Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00174Z |
| Description | AAV serotype 3 particles contain Cre recombinase under CMV promoter and GFP under independent CMV promoter. |
| Serotype | AAV Serotype 3 |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
Adeno-associated virus (AAV) was originally described as a satellite virus after being observed in electron micrographs of adenovirus. The physical properties of these satellite viruses isolated from different adenovirus preparations, such as capsid sequences and protease digestion patterns, are serologically distinct. These satellite viruses have been shown to be defective and require the function of a helper virus for efficient replication. As a result, AAV is considered replication-defective and is now classified in the genus Dependovirus of the subfamily Parvovirinae. Early studies showed that human seroprevalence of some serotypes exceeded 50%, and similar prevalence rates continue to be documented recently. However, even in the presence of high seroprevalence, AAV is considered non-pathogenic, a most desirable feature for virotherapy.
The structure of AAV is very simple. The genome consists of less than 4700 single-stranded bases. The ends of the genome are identical 145-base inverted terminal repeats (ITRs) that form a "T"-shaped hairpin due to base pairing of approximately 116/145 bases. The terminal repeats contain sequences for replication (rep) protein binding and nicking, and importantly, the ITRs are the only cis sequences required for packaging of the recombinant genome. Wild-type AAV ITRs flank two coding domains. First, the 5' domain encodes the four rep proteins (rep 78 kDa/68 kDa and rep 52 kDa/40 kDa). Size differences depend on promoter usage, map position (p) 5 or p 19, and alternative splicing.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
As a researcher focusing on precise genetic modifications, the AAV3-Cre-GFP exceeded our expectations. It has streamlined our workflow significantly, reducing time spent on verification and allowing us to focus on analysis.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.